CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 46 enrolled
Drug / intervention
habit reversal training (HRT)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03621059
NCT03621059N/ACompleted
CompareCT.gov

Behavioral Therapy for Children and Adolescents With Tourette Syndrome: A Randomized Controlled Trial in Taiwan

Taipei Medical University·interventional·Posted Aug 8, 2018·Updated Aug 8, 2018

In Brief

A clinical study evaluating habit reversal training (HRT) for Tourette Syndrome. Completed, enrolled 46 participants.

Detailed Summary

Tourette Syndrome (TS) is a common neuropsychiatric disorder in childhood and adolescence, and often comorbid with psychiatric comorbidity. Antipsychotic medications are usually the first choices, but may associate with adverse effects. Behavioral intervention for TS has been shown to be an effective treatment for children and adolescents, yet have not been performed and evaluated using control trails in Taiwan.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTourette Syndrome
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 8, 2018
Enrollment StartJan 1, 2015
Primary CompletionSep 30, 2016
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 7.9 years ago

Interventions

habit reversal training (HRT)behavioral

The intervention group received 4 sessions during 3months of behavior intervention and then, were reassessed at 3 and 6 months following treatment. Pyridoxine(50mg)